FDA Investigator: Laura Fontan

- Laura Fontan first started conducting FDA inspections in 2014, with the last inspection in 2023. Over that time, Laura Fontan has conducted 24 inspections at 22 companies across 22 sites.

Get Laura Fontan's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Octapharma Produktionsgesellschaft Deutschland mbH, Springe | 2023

Out-of-stock
Laura Fontan
Biologics Form 483

FDA 483 BioMarin Pharmaceutical Inc., Novato | 2022

Out-of-stock
Laura Fontan
Biologics Form 483

FDA 483 FinVector Oy, Kuopio | 2022

Out-of-stock
Laura Fontan
Biologics Form 483

FDA 483 FinVector Oy, Kuopio | 2020

Out-of-stock
Laura Fontan
Biologic Form 483

FDA 483 CoreRX Inc., Clearwater | 2019

Out-of-stock
Laura Fontan
Biologic Form 483

FDA 483 CSL Behring L.L.C., Bradley | 2018

Out-of-stock
Laura Fontan
Biologic Form 483

FDA 483 LEK Pharmaceuticals d.d., Ljubljana | 2018

Out-of-stock
Laura Fontan
Human Drug Form 483

FDA 483 BioMarin International Limited, Ringaskiddy | 2017

Out-of-stock
Laura Fontan
Human Drug Form 483

FDA 483 Amgen, Inc., Thousand Oaks | 2017

Out-of-stock
Laura Fontan
Human Drug Form 483

FDA 483 Hovione FarmaCiencia SA, Loures | 2017

Out-of-stock
Laura Fontan
Human Drug Form 483

FDA 483 G & W Laboratories, Inc., South Plainfield | 2017

Out-of-stock
Laura Fontan
Human Drug Form 483

FDA 483 Lonza Biologics Porrino, O Porrino (Casco Urbano) | 2016

Out-of-stock
Laura Fontan
Human Drug Form 483

FDA 483 Lonza Biologics Porrino, O Porrino (Casco Urbano) | 2016

Out-of-stock
Laura Fontan
Human Drug Form 483

FDA 483 Piramal Pharma Solutions Inc, Lexington | 2016

Out-of-stock
Laura Fontan
Human Drug Form 483